Bisphosphonates in the adjuvant treatment of cancer: experimental evidence and first clinical results

por Diel, I J, Mundy, G R
Publicado 2000

Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studie...

por Body, J J, Diel, I J, Lichinitzer, M, Lazarev, A, Pecherstorfer, M, Bell, R, Tripathy, D, Bergstrom, B
Publicado 2004

Prognostic relevance of urokinase plasminogen activator detection in micrometastatic cells in the bone marrow of patients with primary breast cancer.

por Solomayer, E. F., Diel, I. J., Wallwiener, D., Bode, S., Meyberg, G., Sillem, M., Gollan, C., Kramer, M. D., Krainick, U., Bastert, G.
Publicado 1997

Serum bone sialoprotein as a marker of tumour burden and neoplastic bone involvement and as a prognostic factor in multiple myeloma

por Woitge, H W, Pecherstorfer, M, Horn, E, Keck, A-V, Diel, I J, Bayer, P, Ludwig, H, Ziegler, R, Seibel, M J
Publicado 2001